| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer
1 company
Lippoldt Darin serves as a Chief Legal Officer at NBIX. Across recent SEC filings that breaks down to 0 buys and 78 sells. Those positions are worth an estimated $8.9M at current prices.
Historically, Lippoldt Darin's trades have earned a middling insider score of 60/100 across 29 rated trades. Over a 12-month horizon, 39.3% of those trades were profitable, with an average 12-month return of -6.6%.
The biggest single holding is NBIX (~$8.9M) as Chief Legal Officer. The recent filings there lean toward selling, a net 328,073 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | NBIX Neurocrine Biosciences, Inc. | Chief Legal Officer | Sale+OE10b5-1 | 10,000 | $179.60 | $1,796,014.00 | -15.4% | -20.5% | - | |
| Jun 29, 2026 | NBIX Neurocrine Biosciences, Inc. | Chief Legal Officer | Sale+OE10b5-1 | 10,000 | $170.15 | $1,701,492.09 | -15.4% | -17.4% | - | |
| Dec 8, 2025 | NBIX Neurocrine Biosciences Inc | Chief Legal Officer | Sale+OE10b5-1 | 4,376 | $159.65 | $698,615.27 | -9.2% | -16.2% | - | |
| Feb 13, 2025 | NBIX Neurocrine Biosciences Inc | Chief Legal Officer | Sale+OE10b5-1 | 2,184 | $116.75 | $254,992.44 | -4.8% | +1.6% | +6.2% | |
| Feb 10, 2025 | NBIX Neurocrine Biosciences Inc | Chief Legal Officer | Sale+OE10b5-1 | 911 | $118.25 | $107,727.03 | -2.1% | +1.4% | +15.9% | |
| Jan 31, 2025 | NBIX Neurocrine Biosciences Inc | Chief Legal Officer | Sale+OE10b5-1 | 1,250 | $152.91 | $191,133.00 | -3.0% | -29.8% | -10.4% | |
| Aug 1, 2024 | NBIX Neurocrine Biosciences Inc | Chief Legal Officer | Sale+OE10b5-1 | 2,996 | $154.01 | $461,422.95 | -7.0% | -18.8% | -15.8% | |
| Jul 16, 2024 | NBIX Neurocrine Biosciences Inc | Chief Legal Officer | Sale+OE10b5-1 | 7,004 | $150.00 | $1,050,590.19 | -15.0% | -21.0% | -9.5% | |
| Feb 13, 2024 | NBIX Neurocrine Biosciences Inc | Chief Legal Officer | Sell10b5-1 | 1,098 | $132.99 | $146,028.40 | -2.7% | +1.7% | -12.4% | |
| Feb 8, 2024 | NBIX Neurocrine Biosciences Inc | Chief Legal Officer | Sell10b5-1 | 1,952 | $138.47 | $270,284.02 | -4.8% | +3.4% | -8.8% |